Multiple Manufacturers

CEREBYX

Manufacturer:

Multiple Manufacturers

Cerebyx HCPCS:

Q2009

HCPCS Code Descriptor:

Injection, fosphenytoin, 50 mg phenytoin equivalent

Category:

Q Code

Cerebyx NDCs:

00069-6001-25, 00069-6001-21, 68462-0621-54, 63323-0403-10, 63323-0403-02, 00069-5474-02, 00641-6136-25, 00069-5471-02

Primary Type:

Anti-Convulsant

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00069-6001-25, 00069-6001-21, 68462-0621-54, 63323-0403-10, 63323-0403-02, 00069-5474-02, 00641-6136-25, 00069-5471-02

About Cerebyx:

CEREBYX is a medication manufactured by multiple manufacturers and aligned to the Q Code: Q2009. CEREBYX is administered via the injection route of administration.

ACCESS PRICING AND MORE BY REGISTERING

Q2009 Added Date:

July 1, 2000

Q2009 Effective Date:

January 1, 2020

Q2009 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cerebyx billing and coding information.
Our team did not identify a source for Cerebyx patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for CEREBYX
Our team has not yet identified a source of side effects information for CEREBYX. Please check back in a few weeks.